Antoinette A Amevor1,2, Toshifumi Yodoshi1,2, Andrew T Trout3,4, Jonathan R Dillman3,4, Ruchi Singh1, Ryan Jarvis1, Lin Fei5, Chunyan Liu5, Amy Taylor1,2, Alexander Miethke1,2, Marialena Mouzaki1,2. 1. Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. 2. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. 3. Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. 4. Department of Radiology, University of Cinncinati College of Medicine, Cincinnati, Ohio, USA. 5. Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Abstract
BACKGROUND: Patients with autoimmune hepatitis (AIH) and primary or autoimmune sclerosing cholangitis are at nutritional risk; their body composition and has not been extensively studied. We aimed to describe their body composition and identify clinical links. METHODS: Using magnetic resonance imaging (MRI), two reviewers segmented total psoas muscle area (tPMSA), visceral fat area (VFA) and subcutaneous fat area (mm2 ) and measured visceral and subcutaneous thickness (mm). Clinical, laboratory and quality of life (QoL; using PedsQL) data were collected. Sarcopenia was defined as tPMSA ≤5th percentile. Analysis of variance, Wilcoxon rank test and multivariable modelling were performed. A paediatric cohort with non-alcoholic fatty liver disease (NAFLD) was used as a comparator following propensity score matching. RESULTS: Fifty-eight patients with autoimmune liver disease (AILD) (33 [57%] with AIH) were included: median age 16 years (interquartile range [IQR]: 13-18), 33 (57%) male. Median time from diagnosis to MRI was 15 months (IQR: 2-39 months). Two patients (3%) had a BMIz indicative of mild malnutrition. tPMSA was measurable in 52 subjects (90%). Of those, 25 (48%) had sarcopenia. Sarcopenic patients had a lower blood urea nitrogen compared to non-sarcopenic (median [IQR]: 9.5 [8.0, 12.0] vs 11 [10, 14] mg/dL; P = .023). There was no difference in corticosteroid use between groups. The VFA of sarcopenic patients was higher (3156 [2064, 7492]) vs 2084 [688, 3092]) mm2 ; P = .005). Patient-reported QoL negatively associated with VFA and general health negatively associated with VFA. Compared with NAFLD, the odds ratio for sarcopenia with AILD was 14.5 (95% confidence interval: 2.3-90.7). CONCLUSION: In autoimmune liver diseases, sarcopenia is highly prevalent, associated with increased visceral fat and QoL.
BACKGROUND: Patients with autoimmune hepatitis (AIH) and primary or autoimmune sclerosing cholangitis are at nutritional risk; their body composition and has not been extensively studied. We aimed to describe their body composition and identify clinical links. METHODS: Using magnetic resonance imaging (MRI), two reviewers segmented total psoas muscle area (tPMSA), visceral fat area (VFA) and subcutaneous fat area (mm2 ) and measured visceral and subcutaneous thickness (mm). Clinical, laboratory and quality of life (QoL; using PedsQL) data were collected. Sarcopenia was defined as tPMSA ≤5th percentile. Analysis of variance, Wilcoxon rank test and multivariable modelling were performed. A paediatric cohort with non-alcoholic fatty liver disease (NAFLD) was used as a comparator following propensity score matching. RESULTS: Fifty-eight patients with autoimmune liver disease (AILD) (33 [57%] with AIH) were included: median age 16 years (interquartile range [IQR]: 13-18), 33 (57%) male. Median time from diagnosis to MRI was 15 months (IQR: 2-39 months). Two patients (3%) had a BMIz indicative of mild malnutrition. tPMSA was measurable in 52 subjects (90%). Of those, 25 (48%) had sarcopenia. Sarcopenic patients had a lower blood urea nitrogen compared to non-sarcopenic (median [IQR]: 9.5 [8.0, 12.0] vs 11 [10, 14] mg/dL; P = .023). There was no difference in corticosteroid use between groups. The VFA of sarcopenic patients was higher (3156 [2064, 7492]) vs 2084 [688, 3092]) mm2 ; P = .005). Patient-reported QoL negatively associated with VFA and general health negatively associated with VFA. Compared with NAFLD, the odds ratio for sarcopenia with AILD was 14.5 (95% confidence interval: 2.3-90.7). CONCLUSION: In autoimmune liver diseases, sarcopenia is highly prevalent, associated with increased visceral fat and QoL.
Authors: Amanda Davies; Aline Nixon; Rafeeq Muhammed; Kostas Tsintzas; Sian Kirkham; Francis B Stephens; Gordon W Moran Journal: Clin Nutr Date: 2019-05-25 Impact factor: 7.324
Authors: Calista M Harbaugh; Peng Zhang; Brianna Henderson; Brian A Derstine; Sven A Holcombe; Stewart C Wang; Carla Kohoyda-Inglis; Peter F Ehrlich Journal: J Pediatr Surg Date: 2017-01-29 Impact factor: 2.545
Authors: Eberhard Lurz; Hiten Patel; Richard G Frimpong; Amanda Ricciuto; Mohit Kehar; Paul W Wales; Alexander J Towbin; Govind B Chavhan; Binita M Kamath; Vicky L Ng Journal: J Pediatr Gastroenterol Nutr Date: 2018-02 Impact factor: 2.839
Authors: Ana Paula Bidutte Cortez; Mauro Batista de Morais; Patrícia da Graça Leite Speridião; Regina Helena Guedes da Motta Mattar; Flávia Calanca; Ulysses Fagundes Neto Journal: J Clin Gastroenterol Date: 2010-03 Impact factor: 3.062